| Dr Paul Winger Hendrix, DO | |
|
1401 Johnston Willis Dr Ste 5500, North Chesterfield, VA 23235-4730 | |
| (804) 560-5827 | |
| (804) 560-5845 |
| Full Name | Dr Paul Winger Hendrix |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 18 Years |
| Location | 1401 Johnston Willis Dr Ste 5500, North Chesterfield, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306039730 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 102202525 (Virginia) | Secondary |
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | 102202525 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Commonwealth Perinatal Services Llc | 1658404991 | 4 |
News Archive
Canada's leaders are playing in the sandbox to build a healthier generation of Canadians. In order to raise awareness about The Sandbox Project, Canadian Members of Parliament, Cabinet Ministers, media personalities, NGO's, families and industry professionals built sandcastles in the World's Largest Sandbox event on Sparks Street in Ottawa on Wednesday.
Kaiser Health News staff writer Mary Agnes Carey writes about the questions stemming from the new health reform law: "David wanted to know how the new health care overhaul law would impact retiree health care coverage.
In Europe, the number of seniors aged 70 and over will increase by 40% in the next 20 years, while those aged 80 and over will more than double. Health authorities and the medical community expect a corresponding increase in the number of people suffering costly and debilitating age-related chronic diseases such as osteoporosis, arthritis, heart and lung diseases and dementia.
Onyx Pharmaceuticals, Inc. has announced that it has acquired an option to license rights to SB1518, an orally available, potent, and selective inhibitor of Janus Kinase 2 (JAK2), and SB1578, also a JAK2 inhibitor, from S*BIO Pte Ltd based in Singapore.
Stereotaxis, Inc. announced today that its new capital order momentum continued to build in the second quarter of 2010. The Company generated new capital orders of $10.2 million, more than doubling new capital orders from the 2009 second quarter and representing a 42% sequential increase over orders in the first quarter of 2010. New orders from North America totaled $5.1 million of the total orders in the quarter.
› Verified 8 days ago
| Entity Name | Commonwealth Perinatal Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033437447 PECOS PAC ID: 1658404991 Enrollment ID: O20100806000149 |
News Archive
Canada's leaders are playing in the sandbox to build a healthier generation of Canadians. In order to raise awareness about The Sandbox Project, Canadian Members of Parliament, Cabinet Ministers, media personalities, NGO's, families and industry professionals built sandcastles in the World's Largest Sandbox event on Sparks Street in Ottawa on Wednesday.
Kaiser Health News staff writer Mary Agnes Carey writes about the questions stemming from the new health reform law: "David wanted to know how the new health care overhaul law would impact retiree health care coverage.
In Europe, the number of seniors aged 70 and over will increase by 40% in the next 20 years, while those aged 80 and over will more than double. Health authorities and the medical community expect a corresponding increase in the number of people suffering costly and debilitating age-related chronic diseases such as osteoporosis, arthritis, heart and lung diseases and dementia.
Onyx Pharmaceuticals, Inc. has announced that it has acquired an option to license rights to SB1518, an orally available, potent, and selective inhibitor of Janus Kinase 2 (JAK2), and SB1578, also a JAK2 inhibitor, from S*BIO Pte Ltd based in Singapore.
Stereotaxis, Inc. announced today that its new capital order momentum continued to build in the second quarter of 2010. The Company generated new capital orders of $10.2 million, more than doubling new capital orders from the 2009 second quarter and representing a 42% sequential increase over orders in the first quarter of 2010. New orders from North America totaled $5.1 million of the total orders in the quarter.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul Winger Hendrix, DO P O Box 741030, Atlanta, GA 30384-1030 Ph: (804) 560-5837 | Dr Paul Winger Hendrix, DO 1401 Johnston Willis Dr Ste 5500, North Chesterfield, VA 23235-4730 Ph: (804) 560-5827 |
News Archive
Canada's leaders are playing in the sandbox to build a healthier generation of Canadians. In order to raise awareness about The Sandbox Project, Canadian Members of Parliament, Cabinet Ministers, media personalities, NGO's, families and industry professionals built sandcastles in the World's Largest Sandbox event on Sparks Street in Ottawa on Wednesday.
Kaiser Health News staff writer Mary Agnes Carey writes about the questions stemming from the new health reform law: "David wanted to know how the new health care overhaul law would impact retiree health care coverage.
In Europe, the number of seniors aged 70 and over will increase by 40% in the next 20 years, while those aged 80 and over will more than double. Health authorities and the medical community expect a corresponding increase in the number of people suffering costly and debilitating age-related chronic diseases such as osteoporosis, arthritis, heart and lung diseases and dementia.
Onyx Pharmaceuticals, Inc. has announced that it has acquired an option to license rights to SB1518, an orally available, potent, and selective inhibitor of Janus Kinase 2 (JAK2), and SB1578, also a JAK2 inhibitor, from S*BIO Pte Ltd based in Singapore.
Stereotaxis, Inc. announced today that its new capital order momentum continued to build in the second quarter of 2010. The Company generated new capital orders of $10.2 million, more than doubling new capital orders from the 2009 second quarter and representing a 42% sequential increase over orders in the first quarter of 2010. New orders from North America totaled $5.1 million of the total orders in the quarter.
› Verified 8 days ago
Mary Lynn Coble, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1212 Koger Center Blvd, North Chesterfield, VA 23235 Phone: 804-897-2100 Fax: 807-897-9074 | |
Garrett Michael Wren, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1212 Koger Center Blvd, North Chesterfield, VA 23235 Phone: 804-897-2100 | |
Kristen Lawson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1212 Koger Center Blvd, North Chesterfield, VA 23235 Phone: 804-897-2100 Fax: 804-897-9074 | |
Kimberly W Mcmorrow, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1212 Koger Center Blvd, North Chesterfield, VA 23235 Phone: 804-897-2100 | |
Molly E Ashby Jackson, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1212 Koger Center Blvd, North Chesterfield, VA 23235 Phone: 804-897-2100 Fax: 804-897-9074 | |
Kenley W Neuman, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1212 Koger Center Blvd, North Chesterfield, VA 23235 Phone: 804-897-2100 Fax: 804-897-9074 | |
Elizabeth Pinkerton, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1212 Koger Center Blvd, North Chesterfield, VA 23235 Phone: 804-897-2100 |